$1.66
-0.02[-1.19%]
At close: Apr 23
$1.66
0[0.00%]
After Hours: 4:40PM EDT
CytomX Therapeutics
(NASDAQ:CTMX)CytomX Therapeutics Stock (NASDAQ:CTMX), Quotes and News Summary
CytomX Therapeutics Stock (NASDAQ: CTMX) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 914.958K |
| Day Range | - - - |
| 52 Wk Range | 1.040 - 2.855 |
| Market Cap | $112.435M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 30 |
| Short Interest | 4.95% |
| Days to Cover | 3.81 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About CytomX Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the Un...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy CytomX Therapeutics (CTMX) stock?
You can purchase shares of CytomX Therapeutics (NASDAQ: CTMX) through any online brokerage.
Who are CytomX Therapeutics's (CTMX) competitors?
Other companies in CytomX Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Anixa Biosciences (NASDAQ:ANIX), Cellectar Biosciences (NASDAQ:CLRB), FibroGen (NASDAQ:FGEN) and Barinthus Biotherapeutics (NASDAQ:BRNS).
What is the target price for CytomX Therapeutics (CTMX) stock?
The latest price target for CytomX Therapeutics (NASDAQ: CTMX) was reported by JP Morgan on Monday, April 22, 2024. The analyst firm set a price target for 0.00 expecting CTMX to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for CytomX Therapeutics (CTMX)?
The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $1.66 last updated April 23, 2024 at 4:40 PM EDT.
Does CytomX Therapeutics (CTMX) pay a dividend?
There are no upcoming dividends for CytomX Therapeutics.
When is CytomX Therapeutics (NASDAQ:CTMX) reporting earnings?
CytomX Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
Is CytomX Therapeutics (CTMX) going to split?
There is no upcoming split for CytomX Therapeutics.
What sector and industry does CytomX Therapeutics (CTMX) operate in?
CytomX Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.